OPEN MINDS Weekly News Wire Strategic Health Care News On April 28, 2009, the Institute of Medicines Committee on Conflict of Interest in Medical Research, Education, and Practice released 16 recommendations to reduce conflicts of interest. The recommendations focus on conflicts involving pharmaceutical, medical device, and biotechnology companies, but seek to manage conflicts without affecting constructive collaborations within industry. Overall, the recommendations encompass the following concepts to strengthen conflict of interest policies across the fields of medical research, education, and practice: To preserve public trust and protect . . .
News Report |